Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer

Journal of Surgical Oncology

Volumn 105, Issue 7, 2012, Pages 655-661

  Kurahara, Hiroshi ^a   Takao, Sonshin ^a   Maemura, Kosei ^a   Mataki, Yuko ^a   Kuwahata, Taisaku ^a   Maeda, Koki ^a   Ding, Qiang ^a   Sakoda, Masahiko ^a   Iino, Satoshi ^a   Ishigami, Sumiya ^a   Ueno, Shinichi ^a   Shinchi, Hiroyuki ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

epithelial mesenchymal transition; lymph node metastasis; mesenchymal epithelial transition; pancreatic cancer

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZEB 1 PROTEIN; ZEB 2 PROTEIN;

AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CELL NUCLEUS; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL EPITHELIAL TRANSITION; PANCREAS CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL; TUMOR GROWTH; TUMOR VOLUME;

AGED; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 84859916768     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23020     Document Type: Article

References (30)

1. Stathis A, Moore MJ,: Advanced pancreatic carcinoma: Current treatment and future challenges. Nat Rev Clin Oncol 2010; 7: 163-172.
2. Woodhouse EC, Chuaqui RF, Liotta LA,: General mechanisms of metastasis. Cancer 1997; 80: 1529-1537. (Pubitemid 27444024)
3. Kalluri R, Weinberg RA,: The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
4. Zeisberg M, Neilson EG,: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437.
5. Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al.: Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res 1998; 18: 4177-4180. (Pubitemid 29043631)
6. Joo YE, Rew JS, Park CS, et al.: Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology 2002; 2: 129-137.
7. Winter JM, Ting AH, Vilardell F, et al.: Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 2008; 14: 412-418. (Pubitemid 351226108)
8. Comijn J, Berx G, Vermassen P, et al.: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-1278. (Pubitemid 32607360)
9. Kang Y, Massague J,: Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 2004; 118: 277-279. (Pubitemid 39061108)
10. Peinado H, Olmeda D, Cano A,: Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428. (Pubitemid 46809165)
11. Vandewalle C, Van Roy F, Berx G,: The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 2009; 66: 773-787.
12. Postigo AA,: Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 2003; 22: 2443-2452. (Pubitemid 36604983)
13. Chua HL, Bhat-Nakshatri P, Clare SE, et al.: NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26: 711-724. (Pubitemid 46204250)
14. Wang Z, Li Y, Kong D, et al.: Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 2009; 69: 2400-2407.
15. Arumugam T, Ramachandran V, Fournier KF, et al.: Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 2009; 69: 5820-5828.
16. Cheng H, Fukushima T, Takahashi N, et al.: Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res 2009; 69: 1828-1835.
17. Gunji N, Oda T, Todoroki T, et al.: Pancreatic carcinoma: Correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer 1998; 82: 1649-1656. (Pubitemid 28208913)
18. Ng WK,: Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: Review of patients over an 8-year period. Cancer 2002; 96: 280-288.
19. Christiansen JJ, Rajasekaran SA, Inge L, et al.: N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: Implications for immunotherapy. Mol Cancer Ther 2005; 4: 704-714. (Pubitemid 40767114)
20. Chaffer CL, Brennan JP, Slavin JL, et al.: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Res 2006; 66: 11271-11278. (Pubitemid 46009956)
21. Hugo H, Ackland ML, Blick T, et al.: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374-383. (Pubitemid 47509716)
22. Sobin LH, editor. " International Union Against Cancer TNM classification of malignant tumours ". 6th edition. New York: Wiley-Liss, Inc; 2002.
23. Hirakawa S, Detmar M, Kerjaschki D, et al.: Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease. Am J Pathol 2009; 175: 2235-2248.
24. Aokage K, Ishii G, Ohtaki Y, et al.: Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2011; 128: 1585-1595.
25. Lang SH, Sharrard RM, Stark M, et al.: Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 2001; 85: 590-599. (Pubitemid 32808286)
26. Yates CC, Shepard CR, Stolz DB, et al.: Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 2007; 96: 1246-1252. (Pubitemid 46625074)
27. Elloul S, Silins I, Trope CG, et al.: Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 2006; 449: 520-528. (Pubitemid 44722320)
28. Bracken CP, Gregory PA, Kolesnikoff N, et al.: A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68: 7846-7854.
29. Burk U, Schubert J, Wellner U, et al.: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582-589. (Pubitemid 351772923)
30. Korpal M, Lee ES, Hu G, et al.: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910-14914.